Elias J. Jabbour, M.D.
NPI 1215108303ActiveIndividual· Internal Medicine, Hematology & Oncology· Houston, TX
Internal Medicine, Hematology & Oncology (M.D.) with Physicians Referral Service, practicing in Houston, Texas. Their prescriptions cost Medicare Part D more than their services did: $120,193 for 160 claims, against $52,119 paid for services in 2024. Amgen Inc. was the largest of 18 companies reporting payments in 2025, $198,443 in all, mostly consulting fees.
Overview
| NPI | 1215108303 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Mar 17, 2008 |
| Last updated in NPPES | Sep 19, 2024 |
| Certified by provider | Sep 19, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hematology & Oncology Primary | 207RH0003X | P8368 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Hematology/Oncology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 143 |
|---|---|
| Services billed | 647 across 14 procedure codes |
| Paid by Medicare | $52,119 |
Part D prescriptions in 2024
| Prescriptions (claims) | 160 · 168 30-day fills |
|---|---|
| Patients | 49 |
| Total drug cost | $120,193 |
| Generic share | 83% of claims |
Education and affiliations
| Graduation year | 1998 |
|---|---|
| Medicare specialty | Hematology/Oncology |
Medical group
- Physicians Referral ServiceHouston, TX · 2,765 clinicians
Industry payments (Open Payments)
- 2025$198,443 · 115 payments from 18 companies
- 2024$231,009 · 153 payments from 24 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Amgen Inc. | $51,949 | 34 |
| Astrazeneca Pharmaceuticals LP | $27,110 | 4 |
| Hikma Pharmaceuticals USA | $23,787 | 11 |
| Autolus Inc | $21,582 | 9 |
| Incyte Corporation | $17,875 | 5 |
What the 2025 payments were for
- Consulting Fee$119,468 · 25 payments
- Travel and Lodging$41,548 · 30 payments
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$18,957 · 3 payments
- Honoraria$11,500 · 1 payment
- Food and Beverage$4,161 · 55 payments
- Debt forgiveness$2,809 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Hematology & Oncology providers in Houston
- 1013837921
- 1063332955
- 1073420493
- 1144140054
- 1205756194
- 1346160777
- 1619897865
- 1689594616
- 1912827809
- 1932029485
- 1386904357
- 1407920069
All Internal Medicine, Hematology & Oncology providers in Texas →